Melanoma Rx May Treat Lung Cancer, Too
Turns out a melanoma medication could also help patients with a different type of cancer.
Advanced Non-Small Cell Lung Cancer Rx Approved
The U.S. Food and Drug Administration today granted accelerated approval for Keytruda (pembrolizumab) to treat patients with advanced (metastatic) non-small cell lung cancer (NSCLC) whose disease has progressed after other treatments and with tumors that express a protein called PD-L1. Keytruda is approved for use with a companion diagnostic, the PD-L1 IHC 22C3 pharmDx test, the first test designed to detect PD-L1 expression in non-small cell lung tumors.
FDA Approves Targeted Rx for Lung Cancer
The U.S. Food and Drug Administration today approved Iressa (gefitinib) for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors harbor specific types of epidermal growth factor receptor (EGFR) gene mutations, as detected by an FDA-approved test.
Lung Cancer Rx Might Outperform Chemo
When you're sick, you may feel like the immune system is a weak tool for protecting the body. But new evidence is showing how medications might activate the immune system to treat a very serious illness — lung cancer.
Trial on Bristol-Myers Squib Drug Stopped Early
Bristol-Myers Squibb Company (NYSE:BMY) today announced that an open-label, randomized Phase 3 study evaluating Opdivo versus docetaxel in previously treated patients with advanced, squamous cell non-small cell lung cancer (NSCLC) was stopped early.
FDA Approves Rx for Combo Treatment of Lung Cancer
The US Food and Drug Administration (FDA) has approved a new medication for the treatment of non-small cell lung cancer (NSCLC).
Single Gene Doubled Risk of Lung Cancer
After decades of public health initiatives, it’s no secret that smoking is bad for your health and can ultimately cause lung cancer.
Timing of Chemotherapy for Lung Cancer
Besides the treatment itself, the timing of chemotherapy given to cancer patients can be important to the success of the treatment.
FDA Approves Zykadia for Late-Stage Lung Cancer
The U.S. Food and Drug Administration today granted accelerated approval to Zykadia (ceritinib) for patients with a certain type of late-stage (metastatic) non-small cell lung cancer (NSCLC).
Lung Cancer Survival in Women Linked to Hormone Therapy
More people die of lung cancer each year than any other kind of cancer. The survival rate among women, however, is better than men — and the reasons aren't exactly clear.